Primary Sclerosing Cholangitis

Surgical Clinics of North America

Volumn 88, Issue 6, 2008, Pages 1385-1407

  Gordon, Fredric D ^a,b  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; ANTIBIOTIC AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLERETIC AGENT; COLCHICINE; COLESTYRAMINE; CORTICOSTEROID; CYCLOSPORIN; FLUOROURACIL; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; ONDANSETRON; OPIATE ANTAGONIST; PENTOXIFYLLINE; PHENOBARBITAL; PLACEBO; PREDNISONE; RIFAMPICIN; TACROLIMUS; URSODEOXYCHOLIC ACID;

ADENOCARCINOMA; BALLOON DILATATION; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; CANCER RISK; CHOLANGIOGRAPHY; CHOLANGITIS; CHOLECYSTECTOMY; CHOLELITHIASIS; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMMON BILE DUCT STONE; COMPRESSION FRACTURE; CONTINENT ILEOSTOMY; CONTROLLED CLINICAL TRIAL; CROHN DISEASE; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG MEGADOSE; ENTERITIS; EXTERNAL BEAM RADIOTHERAPY; HISTOPATHOLOGY; HUMAN; ILEOSTOMY; LABORATORY DIAGNOSIS; LAPAROTOMY; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MONOTHERAPY; OSTEODYSTROPHY; OSTEOPOROSIS; PATHOGENESIS; PLASMAPHERESIS; PORTAL HYPERTENSION; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROCTOCOLECTOMY; PROGNOSIS; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; STEATORRHEA; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VARICOSIS; VITAMIN DEFICIENCY;

CHOLANGITIS, SCLEROSING; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; DIGESTIVE SYSTEM SURGICAL PROCEDURES; HUMANS; MORBIDITY; WORLD HEALTH;

EID: 55249110024     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2008.07.010     Document Type: Review

References (51)

1. 2006 OPTN/SRTR Annual report. Table 9.4a. Available at:. http://www.optn.org/AR2006/904a_rec-dgn_li.htm Accessed March 12, 2008
2. Bahmba K., Kim W.R., Talwalker J., et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 125 (2003) 1364-1369
3. Shrumpf E., and Boberg K.M. Epidemiology of primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 15 (2001) 553-562
4. Boberg K.M., Aadand E., Jahnsen J., et al. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 33 (1998) 99-103
5. Kingham J.G., Kochar N., and Gravenor M.B. Incidence, clinical pattern, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom. Gastroenterology 126 (2004) 1929-1930
6. Hurlbert K.J., McMahon B.J., Deubner H., et al. Prevalence of autoimmune liver disease and Alaska natives. Am J Gastroenterol 97 (2002) 2402-2407
7. Rasmussen H.H., Fallingborg J.F., Mortensen P.D., et al. Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease. Scand J Gastroenterol 32 (1997) 604-610
8. Olsson R., Danielsson A., Jarnerot G., et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 100 (1991) 1319-1323
9. Lee Y.M., and Kaplan M.M. Primary sclerosing cholangitis. N Engl J Med 332 (1995) 924-933
10. Mulder A.H., Horst G., Haagsma E.B., et al. Prevalence and characterization of neutrophil cytoplasmic antibodies and autoimmune liver disease. Hepatology 17 (1993) 411-417
11. Ludwig J., Barham S.S., LaRusso N.F., et al. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis or chronic ulcerative colitis. Hepatology 1 (1981) 632-640
12. Hay J.E. Bone disease in cholestatic liver disease. Gastroenterology 108 (1995) 276-283
13. Said K., Glaumann H., and Bergquist A. Gallbladder disease in patients with primary sclerosing cholangitis. J Hepatol 48 (2008) 598-605
14. Shibata D., Brophy D., Gordon F., et al. Portosystemic shunt for treatment of bleeding ectopic varices with portal hypertension. Dis Colon Rectum 42 (1999) 1581-1585
15. Malhi H., and Gores G.J. Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol 45 (2006) 856-867
16. Donato F., Gelatti U., Tagger A., et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and a lip bias: a case-control study in Italy. Cancer Causes Control 12 (2001) 959-964
17. Shaib Y.H., El-Serag H.B., Davila J.A., et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128 (2005) 620-626
18. Gores G.J. Early detection and treatment of cholangiocarcinoma. Liver Transpl 6 (2000) S30-S34
19. Bergquist A., Ekbom A., Olsson R., et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 36 (2002) 321-327
20. Burak K., Angulo P., Pasha T.M., et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 99 (2004) 523-526
21. Iwatsuki S., Todo S., Marsh J.W., et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 187 (1998) 358-364
22. Meyer C.G., Penn I., and James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 69 (2000) 1633-1637
23. Lang H., Sotiropoulos G.C., Domland M., et al. Extended hepatectomy before intrahepatic cholangiocellular carcinoma (ICC)-when is it worthwhile? Single-center experience with 27 receptions in 50 patients over a five-year period. Ann Surg 241 (2005) 134-143
24. Pichlmyer R., Weimann A., Klempnauer J., et al. Surgical treatment in proximal bile duct cancer: a single-center experience. Ann Surg 224 (1996) 628-638
25. Angulo P., Pierce D.H., Johnson C.D., et al. Magnetic resonance cholangiography in the evaluation of the biliary tree: its role in patients with primary sclerosing cholangitis. J Hepatol 33 (2000) 520-527
26. Vitellas K.M., Enns R.A., Keogan M.T., et al. Comparison of MR cholangiopancreatographic techniques with contrast-enhanced cholangiography in the evaluation of sclerosing cholangitis. AJR Am J Roentgenol 178 (2002) 327-334
27. LaRusso N.F., Shneider B.L., Black D., et al. Primary sclerosing cholangitis: summary of a workshop. Hepatology 44 (2006) 746-764
28. Weisner R.H., Grambsch P.M., Dickson E.R., et al. Primary sclerosing cholangitis: natural history, prognostic factors, and survival analysis. Hepatology 10 (1989) 430-436
29. Porayko M.K., Weisner R.H., LaRusso N.F., et al. Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology 98 (1990) 1594-1602
30. Farrant J.M., Hayllar K.M., Wilkinson M.L., et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 100 (1991) 1710-1717
31. Helzberg J.H., Petersen J.M., and Boyer J.L. Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients. Gastroenterology 92 (1987) 1869-1875
32. Aadland E., Schrumpf E., Fausa O., et al. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 22 (1987) 655-664
33. Bjornsson E., Olsson R., Bergquist A., et al. The natural history of small duct primary sclerosing cholangitis. Gastroenterol 134 (2008) 975-980
34. Dickson E.R., Murtaugh P.A., Wiesner R.H., et al. Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 103 (1992) 1893-1901
35. Broom U., Olsson R., Loof L., et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38 (1996) 610-615
36. Kim W.R., Therneau T.M., Wiesner R.H., et al. A revised natural history model for primary sclerosing cholangitis. Mayo Clinic Proc 75 (2000) 688-694
37. Lee Y.M., and Kaplan M.M. ACG Practice Guidelines Committee. Practice guidelines for management of primary sclerosing cholangitis. Am J Gastroenterol 97 (2002) 528-534
38. Lindor K.D., and Mayo PSC/UDCA Study Group. Ursodiol for the treatment of primary sclerosing cholangitis. N Engl J Med 336 (1997) 691-695
39. Olsson R., Boberg K.M., Schaffalitsky de Muckadell O., et al. High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter randomized-controlled study. Gastroenterology 129 (2005) 1464-1472
40. Mitchell S.A., Bansi D., Hunt N., et al. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology 121 (2001) 900-907
41. Harnois D.M., Angulo P., Jorgensen R.A., et al. High-dose ursodeoxycholic acid in primary sclerosing cholangitis. Am J Gastroenterol 96 (2001) 1558-1562
42. Hoofnagle J.H. This month from the NIH: primary sclerosing cholangitis. Hepatology 41 (2005) 955
43. Allison M.C., Burroughs A.K., Noone P., et al. Biliary lavage with corticosteroids in primary sclerosing cholangitis. A clinical, cholangiographic, and bacteriological study. J Hepatol 3 (1986) 118-122
44. Kaplan M.M. Toward better treatment for primary sclerosing cholangitis. N Engl J Med 336 (1997) 719-721
45. Hommes D.W., Erkelens W., Ponsioen C., et al. A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis. J Clin Gastroenterol 42 (2008) 522-526
46. Olsson R., Broomé U., Danielsson A., et al. Colchicine treatment of primary sclerosing cholangitis. Gastroenterology 108 (1995) 1199-1203
47. Baluyut A.R., Sherman S., Lehman G.A., et al. Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis. Gastrointest Endosc 53 (2001) 308-312
48. Cangemi J.R., Wiesner R.H., Beaver S.J., et al. Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis. Gastroenterology 96 (1989) 790-794
49. Roberts M.S., Angus D.C., Bryce C.L., et al. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 10 (2004) 886-897
50. Brandsaeter B., Broome U., Isoniemi H., et al. Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list. Liver Transpl 9 (2003) 961-969
51. Gores G.J., Nagorny D.M., and Rosen C.B. Cholangiocarcinoma: is transplantation an option? For whom?. J Hepatol 47 (2007) 455-459